Statistics for Novavax (id:7890 NVAX)
Valuation metrics
Market cap
1.25B
Enterprise value
525.25M
Trailing P/E (ttm)
-1.57
Forward P/E
-48.94
PEG ratio
-48.94
Price/Sales (ttm)
1.42
Price/Book (mrq)
-2.58
Enterprise Value/Revenue
0.59
Enterprise Value/EBITDA
-2.16
Overview
Shares outstanding
160.18M
Float
143.38M
Shares short
39.98M
% Held by insiders
0.04%
% Held by institutions
0.60%
Average volume (10 days)
7.42M
Average volume (90 days)
Price summary
52-Week low
3.53
52-Week high
23.86
52-Week change
35.54%
Beta
2.09
50-Day moving average
11.26
200-Day moving average
10.03
Dividends and splits
Forward annual dividend rate
Forward annual dividend yield
Trailing annual dividend rate
0.00%
Trailing annual dividend yield
0.00
5-Year annual dividend yield
Payout ratio
0.00
Dividend date
May 10th, 2019
Ex-dividend date
Last split factor
2:1
Last split date
May 10th, 2019
Financials
Fiscal yearFiscal year ends
December 31th, 2023
Most recent quarter (mrq)
September 30th, 2024
Profitability
Profit margin
-32.18%
Operating margin
-153.61%
Operational effectiveness
Return on assets
-10.76%
Return on equity
76.03%
Income statement
Revenue (ttm)
6.19
Revenue per share (ttm)
6.19
Quarterly revenue growth (yoy)
1.80
Gross profit (ttm)
212.61M
EBITDA
-243,246,000.00
Net income to common (ttm)
-284,857,984.00
Diluted EPS (ttm)
-2.18
Quarterly earnings growth (yoy)
179.90%
Balance sheet
Total cash (mrq)
909.53M
Total cash per share (mrq)
5.68
Total debt (mrq)
262.22M
Total Debt/Equity (mrq)
-0.50
Current ratio (mrq)
93.50%
Book value per share (mrq)
-3.29
Cash flow
Cash flow statement
-90,881,000.00
Levered free cash flow (LFCF)
-247,394,256.00